The British Heart Foundation (BHF) was funding around 900 trials involving over 1,500 researchers. Dr Sonya Babu-Narayan, the BHF associate medical director, said: “Unfortunately, much of our research has been disrupted, with universities closing and clinical trials delayed due to the pandemic.
“We need to ensure that patients and the public can still reap the benefits of BHF research. Our priority is that the research we are funding is successfully completed, and our researchers are fully supported.”
Elsewhere, most major drugs companies have had to stop trials. In March, Geneva-based Addex announced that it would delay the start of a clinical trial to treat involuntary movements in people with Parkinson’s disease.
The US pharmaceutical giant Eli Lilly said it would halt enrolment in 86 ongoing studies and delay the launch of new trials including 30 in their final phases.
GSK has paused new trial recruitment, while Roche said it had
Remdesivir is a broad-spectrum antiviral which was developed by pharmaceutical company Gilead more than a decade ago to cure an unknown "Disease X" amid fears that a global pandemic was looming. More than a dozen centres across the NHS have been trialling the...
The NHS is to press ahead with the trial of a controversial drug endorsed by Donald Trump, despite warnings by the World Health Organisation (WHO) that it makes death from coronavirus more likely. The Oxford University-led trial of hydroxychloroquine, originally a...